logo

Michael Carducci, MD

Michael Carducci, MD

Oncology Baltimore, MD

Professor of Medicine, Johns Hopkins University

Office Address

Office Map
  • 600 N Wolfe St
    Baltimore, MD 21287
    Phone: (410) 955-8964

Dr. Carducci's Clinical Specialties & Interests

  • Oncology: General Oncology

Dr. Carducci's Education & Medical Training

  • Johns Hopkins UniversityJohns Hopkins UniversityFellowship, Medical Oncology
  • University of ColoradoUniversity of ColoradoResidency, Internal Medicine
  • Wayne State Univ Sch of MedWayne State University School of MedicineMedical School

Dr. Carducci's Certifications & Licensure

  • DC State Medical LicenseDC State Medical License2012 - 2014
  • MD State Medical LicenseMD State Medical License1992 - 2014
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Carducci's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Phase I Clinical Trials Of New Anti-Cancer Targeted Therapies
    Phase I Clinical Trials Of New Anti-Cancer Targeted TherapiesNational Cancer Institute
    2008 - 2012
  • Foreign Accrual For U01ca70095 - 2006 Load.
    Foreign Accrual For U01ca70095 - 2006 Load.National Cancer Institute
    2006 - 2006
  • DSM
    DSMNational Cancer Institute
    2006 - 2010
  • Phase I Clinical Trials Of New Anti-Cancer Targeted Ther
    Phase I Clinical Trials Of New Anti-Cancer Targeted TherNational Cancer Institute
    2003 - 2007
  • Restoration Of Gene Function In Prostate Cancer
    Restoration Of Gene Function In Prostate CancerNational Cancer Institute
    2003 - 2003
  • Phase I Trials Of Anticancer Agents
    Phase I Trials Of Anticancer AgentsNational Cancer Institute
    2001 - 2002
  • Dose/Pharmacokinetics Of ABT 627 In Adenocarcinoma
    Dose/Pharmacokinetics Of ABT 627 In AdenocarcinomaNational Center For Research Resources
    2000 - 2002
  • Phase I Trial Of Oral Phenylbutyrate In Solid Tumors
    Phase I Trial Of Oral Phenylbutyrate In Solid TumorsNational Center For Research Resources
    2000 - 2002
  • A Randomized Controlled Phase II Clinical Trial Of Modul
    A Randomized Controlled Phase II Clinical Trial Of ModulDivision Of Cancer Prevention And Control
    1999 - 2000
  • Multiple Dose Study Of Safety Of ABT 627
    Multiple Dose Study Of Safety Of ABT 627National Center For Research Resources
    1998 - 2002
  • Phenylbutyrate Bioactivity Assessment In Prostate Cancer
    Phenylbutyrate Bioactivity Assessment In Prostate CancerNational Cancer Institute
    1997 - 2000
  • Continuous Infusion Phenylbutyrate Given For 120 HRS Every 21 Days
    Continuous Infusion Phenylbutyrate Given For 120 HRS Every 21 DaysNational Center For Research Resources
    1997 - 1997
  • Gene Therapy For Prostate Cancer
    Gene Therapy For Prostate CancerNational Cancer Institute
    1996 - 2000

Hospital Affiliations

Insurance Accepted

  • BCBS Blue Card PPO
  • CareFirst BCBS Maryland POS
  • CareFirst BlueChoice Advantage
  • CareFirst BlueChoice Network POS
  • CareFirst BluePreferred PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Michael Carducci, Dr. Michael Carducci, MD, Dr. M Carducci, Dr. Michael Anthony Carducci

31 Colleague Invites!
Is this you? If so, register to see 31 messages.

Physicians, view Dr. Carducci's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV